XML 14 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Co-Promotion Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2018
Dec. 31, 2019
Co Promotion Agreement [Line Items]      
Accrued expenses and other current liabilities $ 170,731   $ 139,826
Co-Promotion Agreement | Kowa Pharmaceuticals America, Inc.      
Co Promotion Agreement [Line Items]      
Agreement amended date Jul. 25, 2017    
Promotion fee as a percentage of gross margin   18.50%  
Maximum co-promotion tail payments receive period 3 years    
Co-promotion tail payments receivable   $ 17,800  
Accrued co- promotion tail payments   $ 16,600  
Accrued expenses and other liabilities $ 7,700   10,000
Accrued expenses and other current liabilities $ 5,300   $ 6,500